NEW YORK, May 21 (GenomeWeb News) - Lynx Therapeutics has signed a service contract with the National Institute of Mental Health to study gene expression in the brain, the company said today.
...and receive Daily News bulletins.
Already have an account?Login Now.
Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.
An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.
The Wall Street Journal looks into the cost of new gene therapies.
In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.